Koers Acro Biomedical Co., Ltd. Other OTC
Aandelen
ACBM
US0048921052
Voedselverwerking
Omzet 2021 | 1,2 mln. 1,1 mln. | Omzet 2022 | 658K 605K | Marktkapitalisatie | 270 mln. 248 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -7 mln. -6,44 mln. | Nettowinst (verlies) 2022 | -15 mln. -13,79 mln. | EV/omzet 2021 | 233 x |
Nettoliquiditeiten 2021 | 24,08K 22,14K | Nettoschuld 2022 | 98,69K 90,75K | EV/omzet 2022 | 410 x |
K/w-verhouding 2021 |
-32,5
x | K/w-verhouding 2022 |
-17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 50,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,39% | 8,48 mld. | |
+6,26% | 7,6 mld. | |
+7,55% | 6,39 mld. | |
-6,74% | 3,75 mld. | |
-7,57% | 3,71 mld. | |
-1,78% | 1,36 mld. | |
-28,08% | 1,11 mld. | |
+18,29% | 1,02 mld. | |
-9,33% | 924 mln. |